Cfr 312.310
WebAfter normal working hours (8 a.m. to 4:30 p.m.), the request should be directed to the FDA Emergency Call Center, 866-300-4374, e-mail: [email protected]. (2) The licensed physician or sponsor must explain how the expanded access use will meet the requirements of §§ 312.305 and 312.310 and must agree to submit an expanded ... Web§ 312.310 Individual patients, including for emergency use. Under this section, FDA may permit an investigational drug to be used for the treatment of an individual patient by a …
Cfr 312.310
Did you know?
Web§ 1010.312 Identification required. Before concluding any transaction with respect to which a report is required under § 1010.311, § 1010.313, § 1020.315, § 1021.311 or § 1021.313 … WebAug 2, 2024 · Brief Summary: This is an open-label, single subject, expanded access protocol (EAP) of the LAM-002A investigational product administered orally at 125 mg BID for 52 weeks. Detailed Description: LAM-002A will be provided for expanded access for an individual patient under 21 CFR 312.310.
WebSep 9, 2024 · Criteria: 21 CFR 312.310 (a) Drug status: The patient cannot obtain the drug under another IND or protocol ( 21 CFR 312.310 (a) ). University of Utah Guidance Single Patient Non-Emergency Use Criteria: 21 CFR 312.310 (a); the patient has a serious condition and is not in an immediately life-threatening situation Webplaced on inactive status (21 CFR 312.45(d)); or, terminated by FDA (21 CFR 312.44(d)) Annual Report : A brief report of the progress of the investigation submitted within 60 days of the
WebIndividual patients, including for emergency use, 21 CFR 312.310. Intermediate-size patient populations, 21 CFR 312.315. Treatment IND or treatment protocol, 21 CFR 312.320. Dooren JC. Connecting patients with experimental drugs. Web21 CFR § 312.305 - Requirements for all expanded access uses. Electronic Code of Federal Regulations (e-CFR) US Law LII / Legal Information Institute. LII. Electronic …
Web§ 312.310 Individual patients, including for emergency use. Under this section, FDA may permit an investigational drug to be used for the treatment of an individual patient by a licensed physician. ( a) Criteria. The criteria in § 312.305 (a) must be met; and the …
WebCFR 312.32, FDA received safety information from these studies that provided important information about drugs under investigation. For this reason, the final rule … starscourge radahn armor setWebPart 312 - INVESTIGATIONAL NEW DRUG APPLICATION Subpart I - Expanded Access to Investigational Drugs for Treatment Use Section 312.310 - Individual patients, including for emergency use. Date April 1, 2011 Citation Text 74 FR 40942, Aug. 13, 2009, as amended at 75 FR 32659, June 9, 2010 Federal Register References 74 FR 40942, 75 FR 32659 starscourge radahn buildWeb§ 312.310 - Individual patients, including for emergency use. Under this section, FDA may permit an investigational drug to be used for the treatment of an individual patient by a … starscourge greatsword is it goodWebTherefore, consistent with 21 CFR 312.10, FDA intends to consider a completed Form FDA 3926 with the box in Field 10 checked, to be a request for a waiver of any additional requirements in 21 CFR part 312 for an IND submission. FORM FDA 3926 SUPPLEMENT (3/16) – FORM INSTRUCTIONS Page 3 of 3 starscourge radahn backgroundWeb• Individual Patient IND, including Emergency Use IND [21 CFR 312.310 ] - commonly held by treating physician or investigator for treatment of an individual patient. See FDA Individual Patient Expanded Access Application Instru ctions. FDA developed Form FDA 3926 specifically for Individual Patient IND request. starscourge greatsword power stanceWebSerious adverse event means an adverse event that results in any of the following outcomes: Death, a life-threatening adverse event as defined in 21 CFR 312.32, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, or … starscourge radahn gifWebJan 17, 2024 · Sec. 312.310 Individual patients, including for emergency use. Under this section, FDA may permit an investigational drug to be used for the treatment of an … starscourge greatsword worth it